KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Common Equity (2016 - 2025)

Historic Common Equity for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $534.1 million.

  • Dynavax Technologies' Common Equity fell 2161.48% to $534.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.1 million, marking a year-over-year decrease of 2161.48%. This contributed to the annual value of $596.8 million for FY2024, which is 406.27% down from last year.
  • Latest data reveals that Dynavax Technologies reported Common Equity of $534.1 million as of Q3 2025, which was down 2161.48% from $494.2 million recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' Common Equity peaked at $681.4 million during Q3 2024, and registered a low of $67.6 million during Q3 2021.
  • Its 5-year average for Common Equity is $459.6 million, with a median of $534.1 million in 2025.
  • In the last 5 years, Dynavax Technologies' Common Equity soared by 74372.46% in 2021 and then crashed by 2312.94% in 2025.
  • Dynavax Technologies' Common Equity (Quarter) stood at $222.4 million in 2021, then surged by 161.28% to $581.0 million in 2022, then grew by 7.07% to $622.1 million in 2023, then decreased by 4.06% to $596.8 million in 2024, then dropped by 10.5% to $534.1 million in 2025.
  • Its last three reported values are $534.1 million in Q3 2025, $494.2 million for Q2 2025, and $530.9 million during Q1 2025.